Literature DB >> 33519694

Case Report: Microglia Composition and Immune Response in an Immunocompetent Patient With an Intracranial Syphilitic Gumma.

Qian Yu1, Wei Li2, Xiaohui Mo3, Fei Tan4, Lianjuan Yang1.   

Abstract

The pathogenesis of intracranial syphilitic gummas remains poorly understood. Microglia are generally considered to be the main cell type of the innate immune system in the brain. Determination of the composition of infiltrating microglia of patients with typical intracranial syphilitic gummas may contribute to the understanding of the pathological process. We report a case of an intracranial syphilitic gumma who presented with right upper limb weakness. The histological analysis showed the presence of Treponema pallidum and infiltration with histiocytes. Immunostaining indicated that cells were predominantly the M2a and M2c, which were Arg-1+ and IL-10+. These findings suggest that there is an increased number of M2a/M2c microglia in intracranial syphilitic gummas, which may be part of the immune escape mechanisms triggered by Treponema pallidum.
Copyright © 2021 Yu, Li, Mo, Tan and Yang.

Entities:  

Keywords:  M2 microglia; Treponema pallidum; humoral immunity; intracranial syphilitic gumma; microglia

Year:  2021        PMID: 33519694      PMCID: PMC7838610          DOI: 10.3389/fneur.2020.615434

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  2 in total

Review 1.  Investigation of the immune escape mechanism of Treponema pallidum.

Authors:  Yun Tang; Yingjie Zhou; Bisha He; Ting Cao; Xiangping Zhou; Lichang Ning; En Chen; Yumeng Li; Xiaoping Xie; Binfeng Peng; Yibao Hu; Shuangquan Liu
Journal:  Infection       Date:  2022-10-19       Impact factor: 7.455

2.  Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male.

Authors:  Khanh Pham; Lee Gottesdiener; Matthew S Simon; Alex Trzebucki; Grace A Maldarelli; Babacar Cisse; Joshua Lieberman; Elliot DeHaan; David Pisapia
Journal:  Open Forum Infect Dis       Date:  2021-08-31       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.